1 Min Read
May 3 (Reuters) - Genkyotex SA:
* Announced on Tuesday it received FDA approval of IND for Phase 2 trial of GKT831 in patients with primary biliary cholangitis Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.